Home > Financial Ratios > BIOCON

BIOCON
Fixed Capital/Sales

    Back to All Ratios
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 2.612.572.452.061.31

What is the latest Fixed Capital/Sales ratio of BIOCON ?

The latest Fixed Capital/Sales ratio of BIOCON is 2.61 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20262.61
Mar20252.57
Mar20242.45
Mar20232.06
Mar20221.31

How is Fixed Capital/Sales of BIOCON Trending?

Years Fixed Capital/Sales % Change
Mar2026 2.61
1.56
Mar2025 2.57
4.90
Mar2024 2.45
18.93
Mar2023 2.06
57.25
Mar2022 1.31 -

Other Financial Ratios of BIOCON


Compare Fixed Capital/Sales ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹63,713.1 Cr -0.7% -6% 7.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-0.7%

-6%

7.1%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses